LORATADIN Mepha cpr 10 mg 14 pce
7680572090017
CH-57209
R06AX13
07.13.1.
1 / 3
google
Details
- Product number
- 5720901
- CPT
- -
- Packaging group
- 14
- Unit
- Tablette(n)
- Composition
- loratadinum 10 mg, lactosum monohydricum 75 mg, cellulosum microcristallinum, maydis amylum, magnesii stearas, pro compresso.
Articles (1)
Loratadin-Mepha, Tabletten
Tabletten
14
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
10.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
75.0 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 8.45
Specialties list
Yes
Generic
Yes
SL addition date:
01/06/2006
Authorization holder
Mepha Pharma AG
4051 Basel
Authorization information
- Swissmedic authorization number
- 57209
- Drug name
- Loratadin-Mepha, Tabletten
- Galenic form
- TAB
- ATC Code
- R06AX13
- Authorization status
- Z
- Dispensation category
- D
- First authorization
- 12/01/2006
- Authorization expiration date
- 31/12/9999
- IT number
- 07.13.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- LORATADIN Mepha cpr 10 mg 14 pce
- Description (DE)
- LORATADIN Mepha Tabl 10 mg 14 Stk
- Market launch
- 12/01/2006
- Narcotic (BTM)
- No